• ქართული
  • English
  • Biogen profit rises 72% on multiple sclerosis therapy sales

    Biogen Inc posted a 72% rise in quarterly profit and lifted its 2019 earnings forecast on Tuesday, boosted by higher sales of its top-selling multiple sclerosis therapy Tecfidera.

    Market Quotes by TradingView